Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.03%
#3 CoW Protocol CoW Protocol +41.64%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +23.75%
#6 Walrus Walrus +22.87%
#7 Enso Enso +21.16%
#8 Tutorial Tutorial +17.28%
#9 Codatta Codatta +16.14%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Classifica tra le azioni #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Prezzo delle azioni
$0.117
Ultima sincronizzazione: 2025-04-04
Capitalizzazione di mercato
$2.45M
Variazione (1 giorno)
-13.59%
Variazione (1 anno)
0.00%
Paese
US
Scambia Carmell Therapeutics Corporation (CTCX)

Categoria

Healthcare
EPS per Carmell Therapeutics Corporation (CTCX)
EPS al June 2026 TTM: $-4.71
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Carmell Therapeutics Corporation, l’EPS attuale della società (TTM) è $-4.71. Alla fine del 2023, la società aveva un EPS di $-0.74 un aumento rispetto a rispetto a quello del 2022, che era di $-0.50.
Storico EPS per Carmell Therapeutics Corporation da 2021 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -467.73%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -688.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -390.87%
BE